Asset Allocation

As of January 31, 2026.
Type % Net
Cash 14.21%
Stock 30.14%
Bond 55.25%
Convertible 0.00%
Preferred 0.36%
Other 0.04%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 62.77%    % Emerging Markets: 1.37%    % Unidentified Markets: 35.86%

Americas 59.66%
57.93%
Canada 5.57%
United States 52.35%
1.73%
Brazil 1.00%
Colombia 0.32%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.49%
United Kingdom 0.68%
2.80%
Denmark 0.06%
Finland 0.01%
France 0.92%
Germany 0.21%
Ireland 0.12%
Netherlands 0.82%
Norway 0.24%
Sweden 0.12%
Switzerland 0.06%
0.00%
0.01%
Israel 0.01%
Greater Asia 0.99%
Japan 0.11%
0.55%
Australia 0.43%
0.33%
Hong Kong 0.09%
Singapore 0.24%
0.00%
Unidentified Region 35.86%

Bond Credit Quality Exposure

AAA 0.16%
AA 18.60%
A 4.69%
BBB 15.01%
BB 27.94%
B 18.01%
Below B 7.04%
    CCC 6.96%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.09%
Not Rated 0.10%
Not Available 8.46%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical --
Materials --
Consumer Discretionary --
Financials --
Real Estate --
Sensitive --
Communication Services --
Energy --
Industrials --
Information Technology --
Defensive --
Consumer Staples --
Health Care --
Utilities --
Not Classified --
Non Classified Equity --
Not Classified - Non Equity --
No Data Available
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 23.59%
Corporate 68.37%
Securitized 3.56%
Municipal 0.82%
Other 3.66%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.71%
Less than 1 Year
4.71%
Intermediate
68.36%
1 to 3 Years
11.45%
3 to 5 Years
25.96%
5 to 10 Years
30.95%
Long Term
25.36%
10 to 20 Years
1.27%
20 to 30 Years
23.15%
Over 30 Years
0.93%
Other
1.57%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial